Rho-Kinase/ROCK as a Potential Drug Target for Vitreoretinal Diseases
Rho-associated kinase (Rho-kinase/ROCK) was originally identified as an effector protein of the G protein Rho. Its involvement in various diseases, particularly cancer and cardiovascular disease, has been elucidated, and ROCK inhibitors have already been applied clinically for cerebral vasospasm and...
Main Authors: | Muneo Yamaguchi, Shintaro Nakao, Mitsuru Arima, Iori Wada, Yoshihiro Kaizu, Feng Hao, Shigeo Yoshida, Koh-hei Sonoda |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/8543592 |
Similar Items
-
Branch retinal artery occlusion in the untreated contralateral eye following aflibercept injections during heparin treatment: Possible contribution of a heparin-induced thrombocytopenia-like condition
by: Shintaro Nakao, et al.
Published: (2019-12-01) -
Diabetic vascular hyperpermeability: optical coherence tomography angiography and functional loss assessments of relationships among retinal vasculature changes
by: Mitsuru Arima, et al.
Published: (2021-02-01) -
Publisher Correction: Diabetic vascular hyperpermeability: optical coherence tomography angiography and functional loss assessments of relationships among retinal vasculature changes
by: Mitsuru Arima, et al.
Published: (2021-06-01) -
Rho Kinase in Eye Disease
by: Naoki Okumura, et al.
Published: (2017-01-01) -
Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
by: Takeru Yoshimura, et al.
Published: (2009-12-01)